Follow up of Post-repair Tetralogy of Fallot
- Conditions
- Tetralogy of Fallot
- Registration Number
- NCT00266188
- Lead Sponsor
- Competence Network for Congenital Heart Defects
- Brief Summary
Tetralogy of Fallot is the most frequent complex congenital heart malformation. Over the past five decades, surgical repair has been performed with respectable results. However, relevant postoperative residues frequently remain. Pulmonary insufficiency, in particular, has been identified as a factor limiting the right ventricular function and, accordingly, the quality of life and life expectancy.
With increasing use of cardiac MRI for both measurement of ventricular function and imaging of pulmonary arteries, residual defects have been discovered that were not detectable by echocardiography. There is mounting evidence of right ventricular pressure and volume stress in Fallot patients after surgical correction. At present, it is impossible to detect right ventricular insufficiency at an early stage. Hence, it is to be assumed that right ventricular insufficiency is underdiagnosed and therapeutic action frequently is initiated beyond the point of no return of ventricular function.
The objective of this study is the systematic collection of cross-sectional and longitudinal data from extensive standardised examinations, including MRI, echocardiography, pulmonary function and ergometry tests, ECG and quality of life assessments, in a large number of patients with surgically corrected tetralogy of Fallot, and the setup of a database. The data obtained are supposed to provide information on the long-term outcome of surgical correction, to help establish criteria for necessity and time of re-intervention or re-operation, and to assess the effectiveness of re-interventions and re-operations.
- Detailed Description
In the repair of tetralogy of Fallot, pulmonary insufficiency used to be tacitly accepted as a result of extensive transannular patching (TAP) and considered unobjectionable. In fact, this is well tolerated during the first postoperative years, but today there is increasing evidence that the resulting chronic volume stress to the right ventricle is harmful on the long run, in particular if there are stenoses of the pulmonary artery in addition. Such stenoses, partly due to distortions after shunt surgery, together with pulmonary insufficiency, lead to a combined volume and pressure load of the right ventricle. The chronic volume stress results in a decrease in biventricular function and exercise tolerance, associated with increasing electrical instability with frequent, mostly ventricular, dysrhythmias. This constellation brings about a significantly increased risk of cardiac death.
Pulmonary valve replacement can improve haemodynamics, exercise tolerance and dysrhythmia. However, it is still unclear, which criteria best indicate the need for re-operation or other re-intervention, such as balloon dilatations of peripheral pulmonary stenoses, and what may be the best point in time.
Cardiac MRI has been established as non-invasive method to quantify right and left ventricular function without radiation exposure. Correlating quantitative functional data to clinical conditions may permit the evaluation of factors that influence the long-term course after surgical repair of Fallot's tetralogy.
The objective of this study is to establish a broad database of cross-sectional and longitudinal (after one year) findings from extensive standardised examinations, including MRI, echocardiography, pulmonary function and ergometry tests, ECG, quality of life assessments performed and cardiac catheterisation, if indicated, on a large number of subjects with surgically corrected tetralogy of Fallot. The data obtained are supposed to determine parameters indicating beginning irreversibility of decreased cardiac function, to provide information on the long-term outcome of surgical correction, to help establish criteria for necessity and time of re-intervention or re-operation, and to assess the effectiveness of re-interventions and re-operations.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 406
- Written consent of the patient and/or the patient's legal representative
- Patients with tetralogy of Fallot (including pulmonary atresia with extreme form of VSD ) after corrective operation
- The corrective intervention has to date back to at least one year before study inclusion
- Ergospirometry and MRI examination can be carried out on an outpatient basis (i. e. patients are normally older than 8 years)
- Patients are not selected according to functional status, i. e. in terms of potentially necessary reintervention measures (e. g. cardiac catheter intervention, pulmonary valve replacement)
- Lack of consent
- Tetralogy of Fallot or pulmonary atresia with VSD without corrective operation (or corrective operation that dates back to less than one year before)
- Pulmonary valve agenesia, DORV (if there is a distinct discontinuity between mitral valve and aortic valve)
- Associated severe heart defects (e. g. AV canal)
- Other clinically relevant diseases, such as malignant tumour or florid diseases (in the investigating physician's assessment)
- Patient is not able to perform ergospirometry (bicycle/treadmill) or contraindication exists
- Absolute MRI contraindication, e.g. cardiac pacemaker
- Pregnant and breast-feeding patients
- Lack of cardiac catheter findings (or MRI) before initial operation -
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (spiroergometry) - Assessment of the biventricular function via MRI, colour Doppler echocardiography, tissue Doppler and strain-rate imaging in correlation with objective exercise tolerance - Prevalence of cardiac dysrhythmias - Morbidity (i. e. severe unwanted effects [SUE], particularly in relapse interventions, such as interventional cardiac catheter or operation) - Subjective quality of life - Mortality (above all in relapse interventions, such as interventional cardiac catheter or operation)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (14)
Herzzentrum Duisburg
🇩🇪Duisburg, North Rhine-Westphalia, Germany
Universitätsklinikum RWTH Aachen
🇩🇪Aachen, North Rhine-Westphalia, Germany
Universitätsklinikum Muenster
🇩🇪Muenster, North Rhine-Westphalia, Germany
Universitätsklinikum Essen
🇩🇪Essen, North Rhine-Westphalia, Germany
Herz-und Diabeteszentrum Nordrhein-Westfalen
🇩🇪Bad Oeynhausen, North Rhine-Westphalia, Germany
Universitätsklinikum Schleswig-Holstein Campus Kiel
🇩🇪Kiel, North Rhine-Westphalia, Germany
Deutsches Herzzentrum Muenchen
🇩🇪Munich, Bavaria, Germany
Deutsches Kinderherzzentrum
🇩🇪Sankt Augustin, North Rhine-Westphalia, Germany
Universitätsklinikum Tübingen
🇩🇪Tübingen, Baden-Wuerttemberg, Germany
Medizinische Hochschule Hannover
🇩🇪Hannover, Lower Saxony, Germany
Deutsches Herzzentrum Berlin
🇩🇪Berlin, Germany
Universitätsklinikum Charité
🇩🇪Berlin, Germany
Herzzentrum Leipzig
🇩🇪Leipzig, Saxony, Germany
Herzzentrum Hamburg, UKE
🇩🇪Hamburg, Germany